A European regulatory committee now recommends approval of the Alzheimer’s treatment lecanemab a few months after rejecting ...

FDA’s requirement for truthful, balanced risk and benefit information applies to drugmakers, leaving a loophole for both ...

Both butters affected listed cream as an ingredient but didn't contain an allergen disclaimer regarding milk, the FDA said.

Europe's medicines watchdog on Thursday partially approved a marketing request for a long-awaited new treatment for Alzheimer ...

The US Food and Drug Administration announced a proposal to remove oral phenylephrine – a common ingredient in many popular ...

(Reuters) -Merck has signed a licensing agreement worth up to $3.3 billion with Shanghai-based LaNova Medicines to develop, ...

NASHUA, N.H., Nov. 12, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) (“iCAD” or the “Company”) a global leader in clinically proven ...

Exclusive: Keith Hackett, the former referees chief, says his proposals to PGMOL board to test match-day officials was ...

Coronation Street legend Johnny Briggs reportedly cut his daughter Karen out of his will after she broke his heart with her ...

Submitted New Drug Application (NDA) to FDA for TNX-102 SL for fibromyalgia based on two statistically significant Phase 3 studiesGranted Fast ...

The FDA’s proposal isn’t an immediate order; it launches a six-month public comment period, after which the agency will make a final decision on whether to pull it from shelves.